Name
Labtowellness OÜ
Registry code
12069847
VAT number
EE101435710
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
07.03.2011 (13)
Financial year
01.01-31.12
Capital
3 850.00 €
Activity
72111 - Research and experimental development on biotechnology
180 808 €
1 878 €
1%
2 961 €
(estimate is approximate)
184 990 €
2
Submitted
No tax arrears
1%
1%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Oliver Kennik 24.05.1982 (42) | 2% - 94.00 EUR | - | Direct ownership | |
| Taavi Einaste 17.06.1980 (44) | 24% - 906.00 EUR | - | Direct ownership | Founder |
| Silja Laht 05.02.1978 (46) | 12% - 475.00 EUR | - | Direct ownership | Founder |
| DNA Art Development OÜ 11938318 | 1% - 38.00 EUR | - | - | Founder |
| Indrek Kask 15.09.1978 (46) | 61% - 2 337.00 EUR | Board member | Direct ownership | Founder |
| 2019 16.09.2020 | 2020 21.06.2021 | 2021 07.06.2022 | 2022 20.06.2023 | 2023 14.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 240 113 € | 120 213 € | 197 938 € | 183 810 € | 180 808 € |
| Net profit (loss) for the period | 89 171 € | -1 761 € | 45 967 € | 27 431 € | 1 878 € |
| Profit Margin | 37% | -1% | 23% | 15% | 1% |
| Current Assets | 84 018 € | 47 523 € | 62 730 € | 59 941 € | 55 416 € |
| Fixed Assets | 114 714 € | 131 524 € | 149 538 € | 164 377 € | 170 702 € |
| Total Assets | 198 732 € | 179 047 € | 212 268 € | 224 318 € | 226 118 € |
| Current Liabilities | 87 257 € | 69 333 € | 56 587 € | 41 206 € | 41 128 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 111 475 € | 109 714 € | 155 681 € | 183 112 € | 184 990 € |
| Employees | 4 | 3 | 4 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 48 490.35 € | 11 561.71 € | 12 381.13 € | 3 |
| 2023 Q4 | 48 900.9 € | 9 425.46 € | 10 052.68 € | 3 |
| 2023 Q3 | 41 895.21 € | 7 246.09 € | 7 673.76 € | 3 |
| 2023 Q2 | 47 770.29 € | 7 166.13 € | 7 587.33 € | 3 |
| 2023 Q1 | 41 908.31 € | 7 761.4 € | 8 219.47 € | 3 |
| 2022 Q4 | 41 650.43 € | 7 717.71 € | 8 189.5 € | 4 |
| 2022 Q3 | 43 230.2 € | 11 095.07 € | 11 875 € | 4 |
| 2022 Q2 | 55 870.36 € | 10 870.94 € | 11 635.46 € | 4 |
| 2022 Q1 | 55 586.76 € | 12 805.61 € | 11 571.69 € | 4 |
| 2021 Q4 | 55 169.5 € | 10 841.4 € | 11 616.28 € | 4 |
| 2021 Q3 | 41 054.27 € | 10 318.62 € | 11 057.26 € | 4 |
| 2021 Q2 | 47 620.55 € | 10 015.36 € | 10 720 € | 4 |
| 2021 Q1 | 50 079.78 € | 8 561.17 € | 9 163.54 € | 6 |
| 2020 Q4 | 42 858.11 € | 9 258.32 € | 9 885.02 € | 5 |
| 2020 Q3 | 17 987.91 € | 5 167.05 € | 5 488.49 € | 4 |
| 2020 Q2 | 38 790.66 € | 8 821.94 € | 9 440.26 € | 4 |
| 2020 Q1 | 30 980.33 € | 9 788.84 € | 10 457.42 € | 5 |
